Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00308737 · ClinicalTrials.gov registry record · Phase 3
Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes
A Phase 3 study, sponsored by Mannkind Corporation.
- Completed
- Registry status
- Phase 3
- Development phase
- 2,053
- Enrollment target
NCT00308737 is a Phase 3 study that has completed, run by Mannkind Corporation. The registered enrollment target is 2,053 participants.
The verdict
NCT00308737, a Phase 3 study, has completed, sponsored by Mannkind Corporation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,053 participants
- Enrollment target
Study Summary
Pulmonary Safety in Diabetics with T/I
Interventions
- DRUG Usual Care
- DRUG Technosphere® Insulin Inhalation Powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,053 participants |
| Start Date | 2005-06 |
| Est. Completion | 2008-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00308737
The ClinicalTrials.gov registry entry for NCT00308737 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 2,053 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mannkind Corporation, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT00308737 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00308737 about?
NCT00308737 is a clinical study titled "Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes". Pulmonary Safety in Diabetics with T/I
What is the current status of trial NCT00308737?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,053 participants. The study started on 2005-06. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00308737?
The interventions under investigation include: Usual Care (DRUG), Technosphere® Insulin Inhalation Powder (DRUG).
Who is sponsoring clinical trial NCT00308737?
This trial is sponsored by Mannkind Corporation, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.